BNP PARIBAS ASSET MANAGEMENT Holding S.A. Has $66.64 Million Position in Danaher Co. (NYSE:DHR)

BNP PARIBAS ASSET MANAGEMENT Holding S.A. reduced its position in shares of Danaher Co. (NYSE:DHR) by 2.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 296,051 shares of the conglomerate’s stock after selling 7,205 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A.’s holdings in Danaher were worth $66,635,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in the stock. Advisory Services Network LLC increased its stake in Danaher by 68.1% during the 4th quarter. Advisory Services Network LLC now owns 8,712 shares of the conglomerate’s stock worth $1,935,000 after acquiring an additional 3,530 shares during the period. Dorsey Wright & Associates increased its stake in Danaher by 7.3% during the 4th quarter. Dorsey Wright & Associates now owns 20,314 shares of the conglomerate’s stock worth $4,513,000 after acquiring an additional 1,382 shares during the period. Financial Consulate Inc. increased its stake in shares of Danaher by 10.4% in the 4th quarter. Financial Consulate Inc. now owns 3,101 shares of the conglomerate’s stock valued at $689,000 after purchasing an additional 291 shares during the last quarter. Dudley & Shanley Inc. increased its stake in shares of Danaher by 29.6% in the 4th quarter. Dudley & Shanley Inc. now owns 82,830 shares of the conglomerate’s stock valued at $18,400,000 after purchasing an additional 18,930 shares during the last quarter. Finally, Gilbert & Cook Inc. increased its stake in shares of Danaher by 15.3% in the 4th quarter. Gilbert & Cook Inc. now owns 1,979 shares of the conglomerate’s stock valued at $438,000 after purchasing an additional 263 shares during the last quarter. 78.00% of the stock is owned by institutional investors and hedge funds.

In other news, EVP Joakim Weidemanis sold 17,169 shares of the business’s stock in a transaction dated Tuesday, April 27th. The stock was sold at an average price of $258.76, for a total value of $4,442,650.44. Following the transaction, the executive vice president now directly owns 84,420 shares of the company’s stock, valued at approximately $21,844,519.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Walter G. Lohr sold 4,350 shares of the business’s stock in a transaction dated Friday, May 7th. The shares were sold at an average price of $259.32, for a total value of $1,128,042.00. Following the completion of the transaction, the director now directly owns 15,728 shares in the company, valued at $4,078,584.96. The disclosure for this sale can be found here. Insiders sold a total of 24,611 shares of company stock worth $6,361,595 over the last three months. 11.70% of the stock is owned by company insiders.

Several equities analysts have recently issued reports on the company. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell lifted their price target on Danaher from $275.00 to $315.00 in a research note on Friday, April 23rd. Robert W. Baird lifted their price target on Danaher from $249.00 to $270.00 and gave the company an “outperform” rating in a research note on Friday, April 23rd. Wells Fargo & Company lifted their price target on Danaher from $260.00 to $280.00 and gave the company an “overweight” rating in a research note on Thursday, April 29th. Citigroup lifted their price target on Danaher from $275.00 to $315.00 in a research note on Friday, April 23rd. Finally, Jefferies Financial Group raised their price objective on Danaher from $270.00 to $290.00 and gave the company a “buy” rating in a report on Friday, April 23rd. One analyst has rated the stock with a sell rating, two have given a hold rating and twelve have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $265.63.

DHR traded down $1.44 during midday trading on Monday, hitting $252.14. 7,615 shares of the company were exchanged, compared to its average volume of 2,501,257. The firm has a market capitalization of $179.85 billion, a P/E ratio of 51.33, a P/E/G ratio of 1.92 and a beta of 0.72. Danaher Co. has a 1-year low of $155.61 and a 1-year high of $261.43. The firm’s 50 day moving average price is $242.74 and its 200-day moving average price is $232.19. The company has a quick ratio of 1.68, a current ratio of 2.08 and a debt-to-equity ratio of 0.63.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, April 21st. The conglomerate reported $2.52 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.67 by $0.85. The firm had revenue of $6.87 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 12.94% and a net margin of 18.05%. The business’s quarterly revenue was up 58.2% compared to the same quarter last year. During the same period in the previous year, the business earned $1.05 EPS. On average, sell-side analysts predict that Danaher Co. will post 6.05 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 30th. Stockholders of record on Friday, June 25th will be paid a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.33%. The ex-dividend date of this dividend is Thursday, June 24th. Danaher’s dividend payout ratio is 19.00%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

See Also: What are convertible shares? 

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.